Cynthia Schwalm G1 Therapeutics, Inc. (GTHX) insider trading activity

GTHX Quotes by TradingView

Cynthia Schwalm is of G1 Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GTHX, which is worth approximately $0. The most recent transaction as insider was on Sep 18, 2024, when has been sold 15,889 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Cynthia Schwalm Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 18 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
15,889 Reduced 100.0%
0 Common Stock
Sep 18 2024
SELL
Sale (or disposition) back to the issuer
-
20,000 Reduced 55.73%
15,889 Common Stock
Jun 13 2024
BUY
Grant, award, or other acquisition
-
10,000 Added 21.79%
35,889 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
10,000 Added 27.86%
25,889 Common Stock
Jun 23 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 38.63%
15,889 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
4,389 Added 42.7%
5,889 Common Stock

Also insider at

CLBS
CALADRIUS BIOSCIENCES, INC. Healthcare
Director
KDMN
Kadmon Holdings, Inc.
Director
CS

Cynthia Schwalm

Basking Ridge, NJ

Track Institutional and Insider Activities on GTHX

Follow G1 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

News

Receive news related to G1 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GTHX